CeGaT Clinical Trial Service
Dec 20, 2022
German genetic testing and molecular diagnostics company CeGaT has launched a clinical trial service. The firm is providing university hospitals, biotechnology firms, and pharmaceutical companies with next-generation sequencing for clinical studies, including genome, exome, and transcriptome sequencing as well as liquid biopsy testing and HLA typing. The company also offers assistance with trial design, preparation of study documents, communication with study centers, long-term data storage, and sample collection and storage.